Ticker Scorecard - NEO Basics Company: NeoGenomics, Inc. IPO Date: December 10, 2012 Sector: Healthcare Industry: Life Sciences Tools and Services Market Cap: $1.43B Activated in VL: True Average Daily Range Avg Daily Range: $0.34 | 2.22% Avg Daily Range (30 D): $0.48 | 3.33% Avg Daily Range (90 D): $0.38 | 2.52% Institutional Daily Volume Avg Daily Volume: .6M Avg Daily Volume (30 D): .97M Avg Daily Volume (90 D): .65M Trade Size Avg Trade Size (Sh.): 93 Avg Trade Size (Sh.) (30 D): 67 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 3,454 Avg Inst. Trade: $2.16M Avg Inst. Trade (30 D): $1.95M Avg Inst. Trade (90 D): $2.11M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.77M Avg Closing Trade (30 D): $2.28M Avg Closing Trade (90 D): $2.21M Avg Closing Volume: 136.69K     News Feb 17, 2025 @ 10:28 PM Not Just a DEX: How Pineapple’s Mystery Mar... Source: N/A Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Nov 22, 2024 @ 7:27 AM Gene Panel Market to Surpass USD 11.75 Billion by ... Source: Skyquest Aug 15, 2024 @ 2:58 PM Laboratory-Developed Tests (LDTs) World Market For... Source: Researchandmarkets.Com Apr 30, 2024 @ 6:00 PM Where NeoGenomics Stands With Analysts Source: Benzinga Insights Financials   TTM Q4 2024 FY 2024 Basic EPS Diluted EPS Revenue $ 660.57M $ 172M $ 660.57M Gross Profit $ 290.1M $ 77.26M $ 290.1M Net Income / Loss $ -78.73M $ -15.32M $ -78.73M Operating Income / Loss $ -92.11M $ -18.4M $ -92.11M Cost of Revenue $ 370.47M $ 94.74M $ 370.47M Net Cash Flow $ 24.52M $ 5.02M $ 24.52M PE Ratio     Splits Apr 16, 2003:   100:1 Nov 17, 2000:   1:4